Ushbu ish iqtibos qilgan ishlar

154 ta ish

Ish: A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance

Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications
Nida Iqbal, Nida Iqbal, Naveed Iqbal +1
Sharh maqola20146 iqtibos
ABI
Comprehensive review of targeted therapy for colorectal cancer
Yuanhong Xie, Yingxuan Chen, Jing‐Yuan Fang
Sharh maqola20205 iqtibos
ABI
Diagnosis and Treatment of Metastatic Colorectal Cancer
Leah H. Biller, Deborah Schrag
Sharh maqola20214 iqtibos
ABI
The Role of mTOR Signaling as a Therapeutic Target in Cancer
N. V. Popova, Manfred Jücker
Sharh maqola20213 iqtibos
ABI
AKT/PKB Signaling: Navigating the Network
Brendan D. Manning, Alex Toker
Sharh maqola20173 iqtibos
ABI
Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies
Nannan Wang, Yuepeng Cao, Chengshuai Si +5
Sharh maqola20223 iqtibos
ABI
Immune Checkpoint Inhibitors in Cancer Therapy
Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani +6
Sharh maqola20223 iqtibos
ABI
Characteristics of the cancer stem cell niche and therapeutic strategies
Feng Ju, Manar Atyah, Nellie Horstmann +6
Sharh maqola20223 iqtibos
ABI
Small Molecule EGFR Inhibitors as Anti-Cancer Agents: Discovery, Mechanisms of Action, and Opportunities
Tanzida Zubair, Debasish Bandyopadhyay
Sharh maqola20233 iqtibos
ABI
Autophagy, cancer stem cells and drug resistance
Alexandra G. Smith, Kay F. Macleod
Sharh maqola20182 iqtibos
ABI
VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
Yueshui Zhao, Sipeng Guo, Jian Min Deng +13
Sharh maqola20222 iqtibos
ABI
The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer
Jennifer L. Hsu, Mien‐Chie Hung
Sharh maqola20162 iqtibos
ABI
The ErbB/HER family of protein-tyrosine kinases and cancer
Robert Roskoski
Sharh maqola20132 iqtibos
ABI
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?
Giuseppe Bronte, Nicola Silvestris, Marta Castiglia +10
Sharh maqola20152 iqtibos
ABI
Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Gang Niu, Xiaoyuan Chen
Sharh maqola20102 iqtibos
ABI
Microsatellite Instability in Colorectal Cancer
C. Richard Boland, Ajay Goel
Sharh maqola20102 iqtibos
ABI
Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years
Mariusz Pańczyk
Sharh maqola20142 iqtibos
ABI
The emerging clinical relevance of genomics in cancer medicine
Michael F. Berger, Elaine R. Mardis
Sharh maqola20182 iqtibos
ABI
NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon
Sharh maqola20182 iqtibos
ABI
Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
Olivier Gires, Min Pan, Henrik Schinke +2
Sharh maqola20202 iqtibos
ABI
Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
Constantin Ștefani, Daniela Miricescu, Iulia-Ioana Stănescu-Spînu +4
Sharh maqola20212 iqtibos
ABI
Impact of<scp>DNA</scp>damage response defects in cancer cells on response to immunotherapy and radiotherapy
Daniel Czajkowski, Radosław Szmyd, Harriet E. Gee
Sharh maqola20222 iqtibos
ABI
HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target
Selma Ahcene Djaballah, Francesca Daniel, A. Milani +2
Maqola20222 iqtibos
ABI
DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
Dana Jurkovičová, Christiana M. Neophytou, Ana Čipak Gašparović +1
Sharh maqola20222 iqtibos
ABI
Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments
Yuanling Tang, Dandan Li, Jiayu Duan +2
Sharh maqola20232 iqtibos
ABI